Post-Surgical Pain Market to Register Incremental Growth During the Forecast Period (2022-32) – DelveInsight | Key Companies – AcelRx, Trevena, Vivozon, Teikoku Pharma, Nevakar, Oculis, PainReform

 Breaking News
  • No posts were found

Post-Surgical Pain Market to Register Incremental Growth During the Forecast Period (2022-32) – DelveInsight | Key Companies – AcelRx, Trevena, Vivozon, Teikoku Pharma, Nevakar, Oculis, PainReform

March 13
22:02 2023
Post-Surgical Pain Market to Register Incremental Growth During the Forecast Period (2022-32) - DelveInsight | Key Companies - AcelRx, Trevena, Vivozon, Teikoku Pharma, Nevakar, Oculis, PainReform
Delveinsight Business Research LLP
The Post-surgical pain pipeline possesses potential drugs in mid and late-stage developments to be approved in the near future. The major pharma and biotech giants such as Vivozon Inc., PainReform LTD, Inc., Nevakar, Inc., and others can potentially create a significant positive shift in the Post-surgical Pain treatment scenario and market outlook.

As per DelveInsight, the Post-Surgical Pain therapeutics market is anticipated to evolve immensely due to the increasing number of surgical procedures, the rise in the patient population of Post-surgical pain, growth in the research and development for new drugs, and the launch of emerging pipeline therapies.

DelveInsight’s “Post-Surgical Pain Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Post-Surgical Pain market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The Post-Surgical Pain market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Post-Surgical Pain Market

Post-Surgical Pain: An Overview

Postoperative pain is an anticipated and temporary increase in background pain that occurs following surgical procedures. It is a type of pain that typically lasts less than a few days to months or pain directly related to soft tissue damage such as a sprained ankle or a paper cut. The pain is of short duration, but it gradually resolves as the injured tissues heal. It is further classified as acute and chronic pain based on the duration.

The intensity, quality, and duration of postoperative pain are affected mainly by the location, type, and duration of the surgical procedure; type and extent of the incision and surgical trauma; the physical and mental state of the patient, including the patient’s personal approach to pain; preoperative psychological and pharmacological preparation; type of anesthesia; pain management before and after the surgical procedure; incidence of surgical complications; and quality of postoperative care.

Post-Surgical Pain Market Key Facts

  • In the 7MM, the total number of incident cases of Post-surgical pain was ~66,000,000+ in 2021.

  • In 2021, the US reported the highest number of surgical procedures, i.e., ~50,300,000+, while the EU5 countries accounted for ~17,000,000+ surgical procedures. 

  • Among the 7MM, the US reported the highest number of incident cases of Post-surgical pain, i.e., ~40,300,000+ in 2021.

  • Japan ranked second among 7MM countries with ~15,300,000+ surgical procedures in 2021.

  • In 2021, Japan accounted for ~12,300,000 cases of Post-surgical pain, which was second-highest after the US among 7MM countries.

  • In 2021, there were ~2,700,000 cases of Post-surgical pain in the UK.

  • In 2021, there were ~1,700,000+ cases of Post-surgical pain in Italy.

Post-Surgical Pain Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Post-Surgical Pain market size by analyzing the impact of current and emerging pipeline therapies. It also thoroughly assesses the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Post-Surgical Pain market trendfor each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MOA), Route of Administration (ROA), molecule types, competition with other therapies, brand value, and their impact on the market.

Post-Surgical Pain Epidemiology Assessment 

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and views of key opinion leaders. 

The Report Covers the Post-Surgical Pain Epidemiology, Segmented as –

  • Total number of surgical procedures in the 7MM [2019–2032]

  • Total incident cases of Post-surgical pain in the 7MM [2019–2032]

  • Severity-specific incident cases of Post-surgical pain in the 7MM [2019–2032]

Post-Surgical Pain Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the uptake rate of potential drugs recently launched in the Post-Surgical Pain market or expected to be launched during the study period. The analysis covers the Post-Surgical Pain market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Post-Surgical Pain pipeline development activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How the Post-Surgical Pain Market Will Evolve and Grow by 2032 @

Post-Surgical Pain Therapeutics Analysis

Postoperative pain management aims not only to decline pain intensity but also to increase patient comfort and improve postoperative outcomes. Pharmacologic therapies for pain include drugs from several drug classes. Pain-relieving analgesics include opioids,   anti-inflammatory drugs (NSAIDs), and acetaminophen. Providers also elect to manage acute pain with benzodiazepines, muscle relaxants, antidepressants, alpha-2 agonists, gamma-aminobutyric agonists, and cannabinoids. Topical agents, such as capsaicin and lidocaine, are also used.

Current treatment for postoperative pain involves approved drugs such as Anjeso, Dextenza, Inveltys, etc., in NSAIDs and corticosteroids. Some approved opioid medications are also present in the market, such as Dsuvia, approved in 2018 in the US and the EU. Some other approved drugs that are being used in postoperative pain are Exparel and others. 

Several major pharma and biotech giants are actively working in the Post-Surgical Pain Therapeutics Market to further improve the treatment scenario.

Leading Companies in the Post-Surgical Pain Therapeutics Market Include:

  • AcelRx Pharmaceuticals

  • AcelRx Pharmaceuticals

  • Trevena, Inc.

  • Heron Therapeutics

  • Vivozon, Inc.

  • Teikoku Pharma USA, Inc.

  • Nevakar, Inc.

  • Taiwan Liposome Company (TLC)

  • Oculis

  • PainReform LTD

  • Concentric Analgesics

And many others

Post-Surgical Pain Marketed and Emerging Therapies Covered in the Report Include:

  • Dsuvia/Dzuveo (Sufentanil): AcelRx Pharmaceuticals

  • Olinvyk (Olinvo) (oliceridine): Trevena, Inc.

  • Zynrelef (HTX-011): Heron Therapeutics

  • VVZ-149 Injections: Vivozon, Inc.

  • TPU-006 (Dexmedetomidine Transdermal System (DMTS)): Teikoku Pharma USA, Inc.

  • NVK-009 (Pregabalin and Acetaminophen): Nevakar, Inc.

  • TLC590: Taiwan Liposome Company (TLC)

  • OCS-01: Oculis

  • PRF110: PainReform LTD

  • Vocacapsaicin (CA-008): Concentric Analgesics

And many more 

The Report Covers the In-depth Assessment of the Emerging Drugs & Key Companies. Download the Sample Report to Learn More @

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Post-Surgical Pain Competitive Intelligence Analysis

4. Post-Surgical Pain Market Overview at a Glance

5. Post-Surgical Pain Disease Background and Overview

6. Post-Surgical Pain Patient Journey

7. Post-Surgical Pain Epidemiology and Patient Population (In the US, EU5, and Japan)

8. Post-Surgical Pain Treatment Algorithm, Current Treatment, and Medical Practices

9. Post-Surgical Pain Unmet Needs

10. Key Endpoints of Post-Surgical Pain Treatment

11. Post-Surgical Pain Marketed Products

12. Post-Surgical Pain Emerging Drugs and Latest Therapeutic Advances

13. Post-Surgical Pain Seven Major Market Analysis

14. Attribute Analysis

15. Post-Surgical Pain Market Outlook (In US, EU5, and Japan)

16. Post-Surgical Pain Access and Reimbursement Overview

17. KOL Views on the Post-Surgical Pain Market

18. Post-Surgical Pain Market Drivers

19. Post-Surgical Pain Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download the Sample PDF to Learn More About the Key Offerings of the Report @


Take control of your healthcare portfolio with DelveInsight’s comprehensive consulting services. Get in touch and discover how we can help you manage your healthcare portfolio today @ Healthcare Portfolio Management Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

Related Articles